Market closed
AcelRx Pharmaceuticals Inc./$TLPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AcelRx Pharmaceuticals Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Ticker
$TLPH
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
13
Website
TLPH Metrics
BasicAdvanced
$8.9M
-
-$0.50
0.19
-
Price and volume
Market cap
$8.9M
Beta
0.19
52-week high
$0.66
52-week low
$0.45
Average daily volume
47K
Financial strength
Current ratio
3.558
Quick ratio
3.348
Long term debt to equity
81.577
Total debt to equity
81.577
Interest coverage (TTM)
-38.71%
Management effectiveness
Return on assets (TTM)
-49.35%
Return on equity (TTM)
-117.65%
Valuation
Price to book
1.11
Price to tangible book (TTM)
1.11
Price to free cash flow (TTM)
-1.061
Growth
Earnings per share change (TTM)
-60.99%
3-year earnings per share growth (CAGR)
-55.88%
TLPH News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for AcelRx Pharmaceuticals Inc. stock?
AcelRx Pharmaceuticals Inc. (TLPH) has a market cap of $8.9M as of April 16, 2025.
What is the P/E ratio for AcelRx Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for AcelRx Pharmaceuticals Inc. (TLPH) stock is 0 as of April 16, 2025.
Does AcelRx Pharmaceuticals Inc. stock pay dividends?
No, AcelRx Pharmaceuticals Inc. (TLPH) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next AcelRx Pharmaceuticals Inc. dividend payment date?
AcelRx Pharmaceuticals Inc. (TLPH) stock does not pay dividends to its shareholders.
What is the beta indicator for AcelRx Pharmaceuticals Inc.?
AcelRx Pharmaceuticals Inc. (TLPH) has a beta rating of 0.19. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.